{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:58:55Z","timestamp":1771657135208,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00347-022-01651-1","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T13:03:50Z","timestamp":1654779830000},"page":"675-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Klinisches Vorgehen bei intraokul\u00e4ren Lymphomen","Clinical procedures for intraocular lymphomas"],"prefix":"10.1007","volume":"119","author":[{"given":"C.","family":"Schiemenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00fcken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Illerhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chronopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kakkassery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"1","key":"1651_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaophthalmol.2013.569","volume":"131","author":"SD Levasseur","year":"2013","unstructured":"Levasseur\u00a0SD, Wittenberg\u00a0LA, White\u00a0VA (2013) Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcome. JAMA 131(1):50. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.569","journal-title":"JAMA"},{"issue":"3","key":"1651_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00347-014-3204-z","volume":"112","author":"N St\u00fcbiger","year":"2015","unstructured":"St\u00fcbiger\u00a0N, Kakkassery\u00a0V, Gundlach\u00a0E, Winterhalter\u00a0S, Pleyer\u00a0U (2015) Diagnostik und Therapie des prim\u00e4ren vitreoretinalen Lymphoms. Ophthalmologe 112(3):223\u2013230. https:\/\/doi.org\/10.1007\/s00347-014-3204-z","journal-title":"Ophthalmologe"},{"issue":"3","key":"1651_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00417-004-0890-2","volume":"243","author":"SE Coupland","year":"2005","unstructured":"Coupland\u00a0SE, Anastassiou\u00a0G, Bornfeld\u00a0N, Hummel\u00a0M, Stein\u00a0H (2005) Primary intraocular lymphoma of T\u2011cell type: report of a\u00a0case and review of the literature. Graefes Arch Clin Exp Ophthalmol 243(3):189\u2013197. https:\/\/doi.org\/10.1007\/s00417-004-0890-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"1651_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00347-018-0681-5","volume":"115","author":"D Jaehne","year":"2018","unstructured":"Jaehne\u00a0D, Coupland\u00a0SE (2018) Prim\u00e4re vitreoretinale Lymphome. Ophthalmologe 115(4):343\u2013356. https:\/\/doi.org\/10.1007\/s00347-018-0681-5","journal-title":"Ophthalmologe"},{"issue":"1","key":"1651_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ophtha.2013.09.004","volume":"121","author":"ME Aronow","year":"2014","unstructured":"Aronow\u00a0ME, Portell\u00a0CA, Sweetenham\u00a0JW, Singh\u00a0AD (2014) Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. Ophthalmology 121(1):334\u2013341. https:\/\/doi.org\/10.1016\/j.ophtha.2013.09.004","journal-title":"Ophthalmology"},{"issue":"1","key":"1651_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ophtha.2013.06.046","volume":"121","author":"A Mashayekhi","year":"2014","unstructured":"Mashayekhi\u00a0A, Shukla\u00a0SY, Shields\u00a0JA, Shields\u00a0CL (2014) Choroidal lymphoma. Ophthalmology 121(1):342\u2013351. https:\/\/doi.org\/10.1016\/j.ophtha.2013.06.046","journal-title":"Ophthalmology"},{"issue":"1","key":"1651_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.survophthal.2020.06.003","volume":"66","author":"V Kakkassery","year":"2021","unstructured":"Kakkassery\u00a0V, Coupland\u00a0SE, Heindl\u00a0LM (2021) Iris lymphoma\u2014a systematic guide for diagnosis and treatment. Surv Ophthalmol 66(1):41\u201353. https:\/\/doi.org\/10.1016\/j.survophthal.2020.06.003","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"1651_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00761-020-00854-y","volume":"26","author":"M Zschoche","year":"2020","unstructured":"Zschoche\u00a0M et\u00a0al (2020) Augenbefall und Systemerkrankung \u2013 periokul\u00e4re und intraokul\u00e4re Lymphome. Onkologe 26(11):1056\u20131064. https:\/\/doi.org\/10.1007\/s00761-020-00854-y","journal-title":"Onkologe"},{"issue":"1","key":"1651_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1442-9071.2012.02811.x","volume":"41","author":"A Mashayekhi","year":"2013","unstructured":"Mashayekhi\u00a0A, Shields\u00a0CL, Shields\u00a0JA (2013) Iris involvement by lymphoma: a\u00a0review of 13\u00a0cases. Clin Experiment Ophthalmol 41(1):19\u201326. https:\/\/doi.org\/10.1111\/j.1442-9071.2012.02811.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"1651_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00347-014-3206-x","volume":"112","author":"D Doycheva","year":"2015","unstructured":"Doycheva\u00a0D, Zierhut\u00a0M, S\u00fcsskind\u00a0D, Bartz-Schmidt\u00a0KU, Deuter\u00a0C (2015) Diagnostik und Therapie der choroidalen Lymphome. Ophthalmologe 112(3):217\u2013222. https:\/\/doi.org\/10.1007\/s00347-014-3206-x","journal-title":"Ophthalmologe"},{"issue":"6","key":"1651_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1442-9071.2008.01843.x","volume":"36","author":"SE Coupland","year":"2008","unstructured":"Coupland\u00a0SE, Damato\u00a0B (2008) Understanding intraocular lymphomas. Clin Experiment Ophthalmol 36(6):564\u2013578. https:\/\/doi.org\/10.1111\/j.1442-9071.2008.01843.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"7","key":"1651_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/IAE.0000000000000145","volume":"34","author":"CL Shields","year":"2014","unstructured":"Shields\u00a0CL, Arepalli\u00a0S, Pellegrini\u00a0M, Mashayekhi\u00a0A, Shields\u00a0JA (2014) Choroidal lymphoma shows calm, rippled, or undulating topography on enhanced depth imaging optical coherence tomography in 14 eyes. Retina 34(7):1347\u20131353. https:\/\/doi.org\/10.1097\/IAE.0000000000000145","journal-title":"Retina"},{"key":"1651_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000331027","volume-title":"Monographs in Clinical Cytology","author":"DJ Chutea","year":"2011","unstructured":"Chutea\u00a0DJ, Biscottia\u00a0CV, Singhb\u00a0AD (2011) Uveal Lymphoma. In: Biscotti\u00a0CV, Singh\u00a0AD (Hrsg) Monographs in Clinical Cytology, Bd. 21. KARGER, Basel, S\u00a031\u201343 https:\/\/doi.org\/10.1159\/000331027"},{"issue":"07","key":"1651_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1055\/s-0041-102900","volume":"232","author":"C Metz","year":"2015","unstructured":"Metz\u00a0C, Schueler\u00a0A, Metz\u00a0K, G\u00f6k\u00a0M, Bornfeld\u00a0N (2015) Transretinale Biopsie beim intraokularen Lymphom. Klin Monatsbl Augenheilkd 232(07):845\u2013849. https:\/\/doi.org\/10.1055\/s-0041-102900","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1651_CR15","first-page":"8","volume-title":"Re-evaluation of \u2018reactive lymphoid hyperplasia of the uvea\u2019","author":"GC Cockerham","year":"2000","unstructured":"Cockerham\u00a0GC, Hidayat\u00a0AA, Bijwaard\u00a0KE, Sheng Z\u2011M (2000) Re-evaluation of \u2018reactive lymphoid hyperplasia of the uvea\u2019. American Academy of Ophthalmology\/Elsevier Science, S\u00a08"},{"issue":"6","key":"1651_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0161-6420(83)34500-0","volume":"90","author":"JA Shields","year":"1983","unstructured":"Shields\u00a0JA, Sanborn\u00a0GE, Augsburger\u00a0JJ (1983) The differential diagnosis of malignant melanoma of the iris. Ophthalmology 90(6):716\u2013720. https:\/\/doi.org\/10.1016\/S0161-6420(83)34500-0","journal-title":"Ophthalmology"},{"issue":"11","key":"1651_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1136\/bjophthalmol-2014-305138","volume":"98","author":"A Chronopoulos","year":"2014","unstructured":"Chronopoulos\u00a0A, Kilic\u00a0E, Joussen\u00a0AM, Lipski\u00a0A (2014) Small incision iris tumour biopsy using a\u00a0cavernous sampling forceps. Br J Ophthalmol 98(11):1539\u20131542. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305138","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1651_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00347-018-0840-8","volume":"116","author":"V Kakkassery","year":"2019","unstructured":"Kakkassery\u00a0V, J\u00fcnemann\u00a0AM, Scheef\u00a0BO, Grisanti\u00a0S, Heindl\u00a0LM (2019) Neue molekularpathologische Ans\u00e4tze bei malignen Iristumoren. Ophthalmologe 116(4):324\u2013331. https:\/\/doi.org\/10.1007\/s00347-018-0840-8","journal-title":"Ophthalmologe"},{"issue":"3","key":"1651_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/09273948.2017.1415362","volume":"27","author":"H Kiratli","year":"2019","unstructured":"Kiratli\u00a0H, A\u011f\u0131n\u00a0A, B\u00fcy\u00fckeren\u00a0B, S\u00f6ylemezo\u011flu\u00a0F (2019) Primary diffuse large B\u2011cell Lymphoma of the ciliary body. Ocular Immunol Inflamm 27(3):407\u2013409. https:\/\/doi.org\/10.1080\/09273948.2017.1415362","journal-title":"Ocular Immunol Inflamm"},{"issue":"9","key":"1651_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00347-013-2905-z","volume":"110","author":"E Biewald","year":"2013","unstructured":"Biewald\u00a0E, Metz\u00a0KA, Bornfeld\u00a0N (2013) Stellenwert der transretinalen Tumorbiopsie als diagnostisches und pr\u00e4diktives Instrument. Ophthalmologe 110(9):882\u2013884. https:\/\/doi.org\/10.1007\/s00347-013-2905-z","journal-title":"Ophthalmologe"},{"issue":"11","key":"1651_CR21","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/annonc\/mdm340","volume":"18","author":"SA Grimm","year":"2007","unstructured":"Grimm\u00a0SA et\u00a0al (2007) Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol 18(11):1851\u20131855. https:\/\/doi.org\/10.1093\/annonc\/mdm340","journal-title":"Ann Oncol"},{"issue":"2","key":"1651_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/09273940902957305","volume":"17","author":"M Mochizuki","year":"2009","unstructured":"Mochizuki\u00a0M, Singh\u00a0AD (2009) Epidemiology and clinical features of Intraocular lymphoma. Ocular Immunol Inflamm 17(2):69\u201372. https:\/\/doi.org\/10.1080\/09273940902957305","journal-title":"Ocular Immunol Inflamm"},{"issue":"11","key":"1651_CR23","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","volume":"16","author":"C Chan","year":"2011","unstructured":"Chan\u00a0C et\u00a0al (2011) Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. The Oncol 16(11):1589\u20131599. https:\/\/doi.org\/10.1634\/theoncologist.2011-0210","journal-title":"The Oncol"},{"issue":"1","key":"1651_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3816\/CLM.2003.n.010","volume":"4","author":"A Hormigo","year":"2003","unstructured":"Hormigo\u00a0A, DeAngelis\u00a0LM (2003) Primary ocular lymphoma: clinical features, diagnosis, and treatment. Clin Lymphoma 4(1):22\u201329. https:\/\/doi.org\/10.3816\/CLM.2003.n.010","journal-title":"Clin Lymphoma"},{"issue":"5","key":"1651_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ajo.2008.12.025","volume":"147","author":"C Fardeau","year":"2009","unstructured":"Fardeau\u00a0C et al (2009) Retinal fluorescein, Indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol 147(5):886\u2013894.e1. https:\/\/doi.org\/10.1016\/j.ajo.2008.12.025","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1651_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/IAE.0b013e3181b408a2","volume":"30","author":"T Ishida","year":"2010","unstructured":"Ishida\u00a0T et\u00a0al (2010) Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina 30(1):23\u201332. https:\/\/doi.org\/10.1097\/IAE.0b013e3181b408a2","journal-title":"Retina"},{"issue":"81","key":"1651_CR27","first-page":"93","volume":"15","author":"C\u2011C Chan","year":"2013","unstructured":"Chan\u00a0C\u2011C (2013) Current concepts in diagnosing and managing primary vitreoretinal (Intraocular) lymphoma. Discov Med 15(81):93\u2013100","journal-title":"Discov Med"},{"key":"1651_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000328266","volume-title":"Developments in Ophthalmology","author":"SE Coupland","year":"2011","unstructured":"Coupland\u00a0SE (2011) Analysis of Intraocular Biopsies. In: Jager\u00a0MJ, Desjardins\u00a0L, Kivel\u00e4\u00a0T, Damato\u00a0B (Hrsg) Developments in Ophthalmology, Bd. 49. KARGER, Basel, S\u00a096\u2013116 https:\/\/doi.org\/10.1159\/000328266"},{"issue":"3","key":"1651_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00347-014-3207-9","volume":"112","author":"A Korfel","year":"2015","unstructured":"Korfel\u00a0A, Schlegel\u00a0U, Schroers\u00a0R (2015) H\u00e4matologische Spezialdiagnostik und Therapieoptionen bei okul\u00e4ren Lymphomen unter Ber\u00fccksichtigung einer ZNS-Beteiligung. Ophthalmologe 112(3):231\u2013236. https:\/\/doi.org\/10.1007\/s00347-014-3207-9","journal-title":"Ophthalmologe"},{"issue":"3","key":"1651_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","volume":"29","author":"D Carbonell","year":"2021","unstructured":"Carbonell\u00a0D et\u00a0al (2021) Consensus recommendations for the diagnosis of vitreoretinal lymphoma. Ocular Immunol Inflamm 29(3):507\u2013520. https:\/\/doi.org\/10.1080\/09273948.2021.1878233","journal-title":"Ocular Immunol Inflamm"},{"key":"1651_CR31","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004212","author":"I Bonzheim","year":"2021","unstructured":"Bonzheim\u00a0I et\u00a0al (2021) The molecular hallmarks of primary and secondary vitreoretinal lymphoma. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2021004212","journal-title":"Blood Adv"},{"issue":"1","key":"1651_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1182\/blood-2015-01-620518","volume":"126","author":"I Bonzheim","year":"2015","unstructured":"Bonzheim\u00a0I et al (2015) High frequency of MYD88 mutations in vitreoretinal B\u2011cell lymphoma: a\u00a0valuable tool to improve diagnostic yield of vitreous aspirates. Blood 126(1):76\u201379. https:\/\/doi.org\/10.1182\/blood-2015-01-620518","journal-title":"Blood"},{"issue":"10","key":"1651_CR33","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00417-012-2037-1","volume":"250","author":"HL Ramkumar","year":"2012","unstructured":"Ramkumar\u00a0HL et al (2012) IL-10-1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefes Arch Clin Exp Ophthalmol 250(10):1541\u20131548. https:\/\/doi.org\/10.1007\/s00417-012-2037-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"23","key":"1651_CR34","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1182\/blood-2017-01-765180","volume":"129","author":"V Kakkassery","year":"2017","unstructured":"Kakkassery\u00a0V et\u00a0al (2017) Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma. Blood 129(23):3130\u20133133. https:\/\/doi.org\/10.1182\/blood-2017-01-765180","journal-title":"Blood"},{"issue":"1","key":"1651_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","volume":"4","author":"JS Pulido","year":"2018","unstructured":"Pulido\u00a0JS, Johnston\u00a0PB, Nowakowski\u00a0GS, Castellino\u00a0A, Raja\u00a0H (2018) The diagnosis and treatment of primary vitreoretinal lymphoma: a\u00a0review. Int J Retin Vitr 4(1):18. https:\/\/doi.org\/10.1186\/s40942-018-0120-4","journal-title":"Int J Retin Vitr"},{"issue":"2","key":"1651_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/ceo.13668","volume":"48","author":"M Kvopka","year":"2020","unstructured":"Kvopka\u00a0M, Lake\u00a0SR, Smith\u00a0JR (2020) Intraocular chemotherapy for vitreoretinal lymphoma: a review. Clin Experiment Ophthalmol 48(2):240\u2013248. https:\/\/doi.org\/10.1111\/ceo.13668","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"1651_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.1.3.1","volume":"1","author":"N Hashida","year":"2012","unstructured":"Hashida\u00a0N, Ohguro\u00a0N, Nishida\u00a0K (2012) Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma. Trans Vis Sci Tech 1(3):1. https:\/\/doi.org\/10.1167\/tvst.1.3.1","journal-title":"Trans Vis Sci Tech"},{"issue":"3","key":"1651_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/09273948.2013.835427","volume":"22","author":"A AlQahtani","year":"2014","unstructured":"AlQahtani\u00a0A et\u00a0al (2014) More than a\u00a0masquerade syndrome: atypical presentations of vitreoretinal lymphomas. Ocular Immunol Inflamm 22(3):189\u2013196. https:\/\/doi.org\/10.3109\/09273948.2013.835427","journal-title":"Ocular Immunol Inflamm"},{"issue":"7","key":"1651_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.2016.79","volume":"29","author":"AK Cani","year":"2016","unstructured":"Cani\u00a0AK et\u00a0al (2016) Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Mod Pathol 29(7):685\u2013697. https:\/\/doi.org\/10.1038\/modpathol.2016.79","journal-title":"Mod Pathol"},{"issue":"S1","key":"1651_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33594\/000000367","volume":"29","author":"V Kakkassery","year":"2021","unstructured":"Kakkassery\u00a0V et\u00a0al (2021) Primary vitreoretinal lymphoma therapy monitoring: significant vitreous haze reduction after Intravitreal rituximab. Neurosignals 29(S1):1\u20137. https:\/\/doi.org\/10.33594\/000000367","journal-title":"Neurosignals"},{"issue":"1","key":"1651_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12885-019-5530-7","volume":"19","author":"M Pei","year":"2019","unstructured":"Pei\u00a0M, Zhao\u00a0C, Gao\u00a0F, Zhang\u00a0M (2019) Bilateral mantle cell lymphoma of the ciliary body that responded to a\u00a0combined local radiotherapy and chemotherapy regimen: a\u00a0case report. BMC Cancer 19(1):355. https:\/\/doi.org\/10.1186\/s12885-019-5530-7","journal-title":"BMC Cancer"},{"issue":"16","key":"1651_CR42","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.3390\/cancers13163921","volume":"13","author":"B Sobolewska","year":"2021","unstructured":"Sobolewska\u00a0B et\u00a0al (2021) Vitreoretinal Lymphoma. Cancers (Basel) 13(16):3921. https:\/\/doi.org\/10.3390\/cancers13163921","journal-title":"Cancers (Basel)"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01651-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01651-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01651-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T08:12:17Z","timestamp":1657095137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01651-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01651-1","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"21 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Schiemenz, S.\u00a0L\u00fcken, A.M.\u00a0Klassen, M.\u00a0Ranjbar, G.\u00a0Illerhaus, F.\u00a0Fend, L.M.\u00a0Heindl, A.\u00a0Chronopoulos, S.\u00a0Grisanti und V.\u00a0Kakkassery geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}